Once commercial production commences at the facility in Q1 2024, it will facilitate the manufacturing of three billion tablets, 15 million syrup bottles and three million units of ointment annually at Dubai Industrial City. In addition, the new herbal pharmaceutical facility in Dubai Industrial City will create hundreds of jobs and export medicines to over 100 countries.

Dubai industrial City and Himalaya have signed a deal for the $32.6m pharmaceutical factory. The proposed factory will sit on 70,606 sq. m of prime land and will be followed by dedicated units for personal care products and functional foods in future.

The plant is expected to be built to the highest standards recognised by the World Health Organisation, the US Food and Drug Administration and the European Medicine Agency’s good manufacturing practices. It aims to enhance global confidence in high-quality Made in UAE products, boost medical security, and support the nation’s industrial strategy, Operation 300Bn.

Commenting on the facility, Abdulla Belhoul, Chief Commercial Officer of Dubai Holding Asset Management, said: “In line with the vision of our leadership, the UAE continues to consolidate its status as a global leader thanks to a raft of infrastructure investments, new initiatives and regulations. Combined, these factors have created a competitive and enabling industrial ecosystem.”

On his part, Saud Abu Al-Shawareb, Managing Director of Dubai Industrial City, said: “We are delighted to enter into this agreement with wellness company Himalaya and believe our competitive ecosystem, with advanced infrastructure and an easy setup process, is the perfect place for its next phase of growth.

For more than a decade, we have been a strategic driver and enabler of Dubai’s knowledge and innovation-based economy and today’s announcement is the latest step forward in our ongoing efforts to position this city as a global hub for advanced manufacturing and logistics.”